Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Lawmakers on both sides of the aisle want China to be less involved in medical supply chains. The health care industry says it needs more incentives to boost domestic production.

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...

We are already shifting supply chains on every board I am on, but getting tough on China economically is also a positive.

The first Donald Trump term focused on curbing the ability of China to rip off American innovation. Biden officials picked up where Trump left off, with new export restrictions on US technology and ...

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous ...

Even during this tense election year, bipartisan coalitions are taking steps to enhance national security, protect American ... the domestic supply chain that renders robust biotech innovation ...

They see Trump's return to the White House as a mixed bag for equities, fixed income and sustainable investing.

Announced by the company a few weeks ago, Two presentations at the upcoming American College of ... impressive teams in the small biotech space. My share supply/demand analysis of trading patterns ...